Are you Dr. Atasoy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-8935
Summary
- Dr. Ajlan Atasoy, MD is an oncologist in Buffalo, New York. She is currently licensed to practice medicine in New York. She is affiliated with Sisters of Charity Hospital of Buffalo.
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2008 - 2011- UPMC Medical EducationResidency, Internal Medicine, 2004 - 2008
Hacettepe University FOMClass of 2001
Certifications & Licensure
NY State Medical License 2016 - 2018
Publications & Presentations
PubMed
- 92 citationsPostoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC.Yi-Long Wu, Thomas John, Christian Grohé, Margarita Majem, Jonathan W. Goldman
Journal of Thoracic Oncology. 2021-11-02 - 3 citationsA plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancerYi-Long Wu, Masahiro Tsuboi, Thomas John, Christian Grohé, Margarita Majem
Future Oncology. 2021-11-01 - 860 citationsOsimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.Yi-Long Wu, Masahiro Tsuboi, Jie He, Thomas John, C. Grohe
The New England Journal of Medicine. 2020-09-19
